veratridine has been researched along with haloperidol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S | 1 |
| Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
| Bronaugh, RL; Ebstein, B; Goldstein, M; Roberge, C | 1 |
| Baruah, S; Davidson, AT; Hegwood, TS; Sherman, AD; Waziri, R | 1 |
| Chavkin, C; Neumaier, JF | 1 |
| el Mestikawy, S; Glowinski, J; Hamon, M | 1 |
| Schmalzing, G | 1 |
| Frohman, LA; Maeda, K | 1 |
| Collu, R; Ducharme, JR; Eljarmak, D; Lafond, J; Marchisio, AM | 1 |
| Krauss, J; Meyer, DK | 1 |
14 other study(ies) available for veratridine and haloperidol
| Article | Year |
|---|---|
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |
Stimulation of tyrosine hydroxylase activity by cyclic AMP in synaptosomes and in soluble striatal enzyme preparations.
Topics: Animals; Apomorphine; Bucladesine; Corpus Striatum; Dose-Response Relationship, Drug; Enzyme Activation; Haloperidol; Kinetics; Limbic System; Male; Ouabain; Rats; Synaptosomes; Tyrosine 3-Monooxygenase; Veratridine | 1976 |
Evidence of glutamatergic deficiency in schizophrenia.
Topics: Aged; Aspartic Acid; Brain Chemistry; Cerebral Cortex; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamates; Glutamic Acid; Haloperidol; Humans; In Vitro Techniques; Male; Middle Aged; Schizophrenia; Synaptosomes; Veratridine | 1991 |
Calcium-dependent displacement of haloperidol-sensitive sigma receptor binding in rat hippocampal slices following tissue depolarization.
Topics: Animals; Calcium; Guanidines; Haloperidol; Hippocampus; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Opioid; Veratridine | 1989 |
Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
Topics: Amphetamine; Animals; Bucladesine; Cerebral Cortex; Clozapine; Corpus Striatum; Dopamine; Enzyme Activation; Haloperidol; Hippocampus; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Sulpiride; Synapses; Synaptosomes; Tyrosine 3-Monooxygenase; Veratridine | 1986 |
The role of a transmembrane pH gradient in uptake and release of imipramine and haloperidol in synaptosomes.
Topics: Animals; Cattle; Caudate Nucleus; Cerebral Cortex; Dopamine; Haloperidol; Hydrogen-Ion Concentration; Imipramine; In Vitro Techniques; Male; Membrane Potentials; Potassium; Rats; Rats, Inbred Strains; Synaptosomes; Veratridine | 1988 |
Release of somatostatin and thyrotropin-releasing hormone from rat hypothalamic fragments in vitro.
Topics: Animals; Bromocriptine; Bucladesine; Calcium; Dopamine; Haloperidol; Hypothalamus; In Vitro Techniques; Levodopa; Male; Neurotransmitter Agents; Potassium; Rats; Somatostatin; Thyrotropin-Releasing Hormone; Veratridine | 1980 |
Sodium ions: their role and mechanism of action in the control of prolactin release.
Topics: Animals; Bromocriptine; Cells, Cultured; Cobalt; Dopamine; Female; Haloperidol; Ouabain; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Sodium; Tetrodotoxin; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide; Veratridine | 1984 |
Dopamine modulates cholecystokinin release in neostriatum.
Topics: Animals; Apomorphine; Calcium; Caudate Nucleus; Cholecystokinin; Dopamine; Dose-Response Relationship, Drug; Haloperidol; In Vitro Techniques; Kainic Acid; Putamen; Rats; Receptors, Dopamine; Tetrodotoxin; Veratridine | 1983 |